|
Pleocytosis, all acute attacks
|
Samples
|
44/79 (55.7%)
|
10/23 (43.5%)
|
|
Pleocytosis, acute MY
|
Samples
|
26/31 (83.9%)
|
6/9 (66.7%)
|
|
Pleocytosis, acute ON
|
Samples
|
12/39 (30.8%)
|
3/11 (27.3%)
|
|
Pleocytosis, acute BRAIN
|
Samples
|
5/7 (71.4%)
|
1/3 (33.3%)
|
|
OCB, all acute attacks
|
Samples
|
7/73 (9.6%)
|
2/23 (8.7%)
|
|
OCB, acute MY
|
Samples
|
1/27 (3.7%)
|
2/10 (20%)#
|
|
OCB, acute ON
|
Samples
|
3/38 (7.9%)
|
0/10 (0%)
|
|
OCB, acute BRAIN
|
Samples
|
2/7 (28.6%)
|
0/3 (0%)
|
|
IgG-IF > 10%, all acute attacks
|
Samples
|
4/63 (6.3%)
|
3/24 (12.5%)
|
|
IgG-IF > 10%, acute MY
|
Samples
|
2/26 (7.7%)
|
0/9 (0%)
|
|
IgG-IF > 10%, acute ON
|
Samples
|
2/31 (6.5%)
|
0/9 (0%)
|
|
IgG-IF > 10%, acute BRAIN
|
Samples
|
0/5 (0%)
|
0/3 (0%)
|
|
QAlb > Qlim(Alb), all acute attacks
|
Samples
|
35/65 (53.8%)
|
7/23 (30.4%)
|
|
QAlb > Qlim(Alb), acute MY
|
Samples
|
16/26 (61.5%)
|
6/10 (60%)
|
|
QAlb > Qlim(Alb), acute ON
|
Samples
|
14/33 (42.4%)
|
1/10 (10%)
|
|
QAlb > Qlim(Alb), acute BRAIN
|
Samples
|
4/5 (80%)
|
0/3 (0%)
|
|
CSF TP elevated, all acute attacks
|
Samples
|
33/70 (47.1%)
|
9/23 (39.1%)
|
|
CSF TP elevated, acute MY
|
Samples
|
15/27 (55.6%)
|
6/10 (60%)
|
|
CSF TP elevated, acute ON
|
Samples
|
14/37 (37.8%)
|
1/10 (10%)
|
|
CSF TP elevated, acute BRAIN
|
Samples
|
4/5 (80%)
|
2/3 (66.7%)
|
|
CSF l-lactate elevated, all acute attacks
|
Samples
|
14/52 (26.9%)
|
2/13 (15.4%)
|
|
CSF l-lactate elevated, acute MY
|
Samples
|
9/21 (42.9%)
|
1/5 (20%)
|
|
CSF l-lactate elevated, acute ON
|
Samples
|
5/28 (17.9%)
|
1/8 (12.5%)
|
|
CSF l-lactate elevated, acute BRAIN
|
Samples
|
0/3 (0%)
|
0/0 (0%)
|
|
Time since attack onset, acute LPs
|
Days
|
7 (0-34)
|
9.5 (0-28)
|
